(Q36468023)

14 August 2017

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer (English)

1 reference

non-small-cell lung carcinoma

14 August 2017

1 reference

1 reference

1 reference

1 reference

Hardy JR

1

1 reference

14 August 2017

Noble T

series ordinal

2

1 reference

14 August 2017

Smith IE

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 November 1989

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

60

1 reference

14 August 2017

5

1 reference

14 August 2017

764-766

1 reference

Reporting results of cancer treatment

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247325

Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247325

Chemotherapy of metastatic non-small cell bronchogenic carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247325

Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247325

Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247325

Treatment of inoperable carcinoma of bronchus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247325

Non-small cell lung cancer: how oncologists want to be treated

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247325

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247325

Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247325

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

21 September 2018

1 reference

12 December 2020

Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trial

1 reference

12 December 2020

Progress in chemotherapy of non-small cell lung cancer

1 reference

12 December 2020

Is there standard chemotherapy for non-small cell lung cancer?

1 reference

12 December 2020

The role of chemotherapy in non-small cell lung cancer: the community perspective

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.355

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

2478183

1 reference